Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South Africa

OBJECTIVES: The high cost of rifampicin‐resistant tuberculosis (RR‐TB) treatment hinders treatment access. South Africa has a high RR‐TB burden, and national policy outlines decentralisation to improve access and reduce costs. We analysed health system costs associated with RR‐TB treatment by drug r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trop Med Int Health
Hlavní autoři: Cox, Helen, Ramma, Lebogang, Wilkinson, Lynne, Azevedo, Virginia, Sinanovic, Edina
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2015
Témata:
Original Research Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864411/
https://ncbi.nlm.nih.gov/pubmed/25975868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tmi.12544
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky